Akebia Therapeutics

After breakup with Otsuka, Akebia finds new partner for oral anemia drug in Europe
Fierce Pharma
Thu, 05/25/23 - 01:07 pm
Akebia Therapeutics
Medice Arzneimittel Pütter
Europe
Australia
Vafseo
chronic kidney disease
Akebia's Appeal for Anemia in CKD Drug Delayed Again
BioSpace
Tue, 02/21/23 - 04:40 pm
Akebia Therapeutics
vadadustat
chronic kidney disease
Sometimes, Clinical Trials Miss the Mark: Neurocrine, Akebia, Eliem and Athira
BioSpace
Fri, 08/5/22 - 10:57 am
clinical trials
Neurocrine Biosciences
Akebia Therapeutics
Eliem Therapeutics
Athira Pharma
In a one-two gut punch after kidney drug CRL, Akebia slapped with partial hold and will lay off 42% of staff
Endpoints
Thu, 04/7/22 - 10:49 am
Akebia Therapeutics
FDA
vadadustat
layoffs
FDA rejects Akebia drug, dealing another blow to anemia pills
BioPharma Dive
Thu, 03/31/22 - 10:24 am
Akebia Therapeutics
vadadustat
FDA
chronic kidney disease
anemia
Akebia tries for FDA approval of anemia drug after mixed data
BioPharma Dive
Tue, 03/30/21 - 10:15 pm
Akebia Therapeutics
anemia
FDA
Blockbusters in waiting: drug launches to watch in 2020
Pharmaforum
Mon, 02/17/20 - 11:33 pm
drug launches
Biohaven
rimegepant
Novartis
ofatumumab
Celgene
ozanimod
Akebia Therapeutics
vadadustat
Biomarin
valrox
Gilead Sciences
filgotinib
Novo Nordisk
oral semaglutide
inclisiran
Immunomedics
sacituzumab govitecan
AstraZeneca
Enhertu
Bristol-Myers Squibb
liso-cel
$1.3 Billion Merger Between Akebia Therapeutics and Keryx Biopharmaceuticals to Focus on Kidney Disease
CP Wire
Thu, 06/28/18 - 09:30 am
Akebia Therapeutics
Keryx
kidney disease
M&A
vadadustat
$1.3 Billion Merger Between Akebia Therapeutics and Keryx Biopharmaceuticals to Focus on Kidney Disease
Thu, 06/28/18 - 09:23 am
Akebia Therapeutics
Keryx
kidney disease
Merrimack employee accused of leaking clinical trial data
Fierce Biotech
Wed, 02/8/17 - 09:40 am
Merrimack
clinical trials
clinical trial data
Akebia Therapeutics
SEC
Biotech employee charged with insider trading based on study results
Stat
Wed, 06/15/16 - 05:44 pm
insider trading
biotech
Akebia Therapeutics
This Past Week’s Top 5 Biotech Movers
24/7 Wall St
Sat, 09/12/15 - 01:31 pm
biotech
Akebia Therapeutics
Clovis Oncology
Mirati Therapeutics
Vivus
Vitae
​Here’s the deal with Akebia’s anemia drug that caused a 50% stock hike today
Bizjournals.com
Wed, 09/9/15 - 10:02 pm
Akebia Therapeutics
anemia
vadadustat
kidney disease
Akebia, MediWound Post Gains Following IPOs
Wall St 24/7
Thu, 03/20/14 - 05:32 pm
Akebia Therapeutics
IPOs
MediWound
IPO Could Be Too Little, Too Early For Akebia Therapeutics
Seeking Alpha
Tue, 03/18/14 - 01:37 pm
IPOs
Akebia Therapeutics
anemia
Akebia Therapeutics Completes Series B
techfinance.ca
Sat, 08/13/11 - 04:11 pm
Akebia Therapeutics